Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in Prediabetes
NCT05426525Phase 4Completed
- Sponsor
- Oregon State University
- Start
- Oct 2022
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in prediabetes, sponsored by Oregon State University. Started Oct 2022; status: completed.
02
Drugs
empagliflozin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT05426525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05426525.